Satellite Symposium at the
26th European Congress of Pathology
Pathologists’ role in CD30 detection:
the first steps toward optimal treatment of haematological malignancies
31 August 2014 13:00–14:30
ExCeL, London, United Kingdom
Capital Suite 8/11

Pier Paolo Piccaluga


Pier Paolo Piccaluga is Associate Professor of Pathology in the Department of Experimental, Diagnostic, and Specialty Medicine at the Bologna University School of Medicine, Bologna, Italy.

He completed his degree in Medicine and Surgery with honours in 1997 at the University of Bologna Medical School. He completed internships in Internal Medicine, Pathology, and Hematology, and a residency in Hematology at the same institution. He received a PhD in Clinical and Experimental Hematology there in 2005. He has also undertook a postdoctoral research fellowship at the Institute for Cancer Genetics at Columbia University Medical Center, New York, NY, USA and, more recently, a residency/fellowship in Pathology at the University of Siena, Italy. He was Visiting Scientist at the Center for Computational Biology and Bioinformatics at Columbia University Medical Center, and Visiting Scientist at the Institut fur Pathologie, Christian-Albrechts-University, Kiel, Germany. His main research interests include pathobiology of peripheral T-cell lymphomas, novel treatments for non-Hodgkin lymphomas, pathobiology of Burkitt lymphoma, biology and treatment of acute myeloid leukemia, biology and treatment of acute lymphoblastic leukemia, and myelofibrosis and microenvironment.

Professor Piccaluga is the author of a number of international publications and presentations at national and international conferences. He is involved in several clinical trials as sub-investigator or coordinator and has won numerous prizes for study and research. He is Associate Editor of the American Journal of Blood Research, Modern Chemotherapy, and World Journal of Hematology, and a member of various societies, including the American Society of Hematology (ASH), American Association for Cancer Research (AACR), and European Hematology Association (EHA).


Wolfram Klapper

Peter Borchmann

Laurence de Leval

Pier Paolo Piccaluga
This meeting is an
Excerpta Medica activity.
Support for this educational activity is provided by
Takeda Oncology.